Literature DB >> 31875511

Polypill for Cardiovascular Disease Prevention in an Underserved Population. Reply.

Thomas J Wang1, Daniel Muñoz1, William J Blot1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31875511      PMCID： PMC7061282          DOI： 10.1056/NEJMc1914047

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.

Authors:  S Yusuf; P Pais; R Afzal; D Xavier; K Teo; J Eikelboom; A Sigamani; V Mohan; R Gupta; N Thomas
Journal:  Lancet       Date:  2009-03-30       Impact factor: 79.321

2.  Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.

Authors:  Gholamreza Roshandel; Masoud Khoshnia; Hossein Poustchi; Karla Hemming; Farin Kamangar; Abdolsamad Gharavi; Mohammad Reza Ostovaneh; Alireza Nateghi; Masoud Majed; Behrooz Navabakhsh; Shahin Merat; Akram Pourshams; Mahdi Nalini; Fatemeh Malekzadeh; Masoumeh Sadeghi; Noushin Mohammadifard; Nizal Sarrafzadegan; Mohammad Naemi-Tabiei; Abdolreza Fazel; Paul Brennan; Arash Etemadi; Paolo Boffetta; Neil Thomas; Tom Marshall; Kar Keung Cheng; Reza Malekzadeh
Journal:  Lancet       Date:  2019-08-24       Impact factor: 79.321

3.  Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

Authors:  Salim Yusuf; Eva Lonn; Prem Pais; Jackie Bosch; Patricio López-Jaramillo; Jun Zhu; Denis Xavier; Alvaro Avezum; Lawrence A Leiter; Leopoldo S Piegas; Alexander Parkhomenko; Matyas Keltai; Katalin Keltai; Karen Sliwa; Irina Chazova; Ron J G Peters; Claes Held; Khalid Yusoff; Basil S Lewis; Petr Jansky; Kamlesh Khunti; William D Toff; Christopher M Reid; John Varigos; Jose L Accini; Robert McKelvie; Janice Pogue; Hyejung Jung; Lisheng Liu; Rafael Diaz; Antonio Dans; Gilles Dagenais
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

Review 4.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

5.  Polypill for Cardiovascular Disease Prevention in an Underserved Population.

Authors:  Daniel Muñoz; Prince Uzoije; Cassandra Reynolds; Roslynn Miller; David Walkley; Susan Pappalardo; Phyllis Tousey; Heather Munro; Holly Gonzales; Wenliang Song; Charles White; William J Blot; Thomas J Wang
Journal:  N Engl J Med       Date:  2019-09-19       Impact factor: 176.079
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.